This editorial refers to 'Endothelin signalling in arterial smooth muscle is tightly regulated by G protein-coupled receptor kinase 2' by G.E. Morris et al., this issue. At the heart of receptor-mediated signal transduction are two intertwined processes: translation of signals carried by stimulating agents to cells through intracellular messenger molecules and termination/ restriction of signalling by cells. The latter is a critical mechanism that protects cells from overreacting to an extended or appropriate stimulus and makes cells ready to react to forthcoming stimulation. G protein-coupled receptors (GPCRs) are a family of receptors composed of seven transmembrane domains that respond to various stimuli. GPCRs usually undergo rapid desensitization after activation, in which GPCR kinases (GRKs), a family consisting of seven members (GRK 1-7), play a critical role. suggesting that a broader spectrum of receptor interaction may exist in vivo. As rat mesenteric SMCs express ET A and ET B among many other receptors, native cells are certainly more suitable for receptor regulation studies than non-muscle cell lines. Third, the origin of the SMC makes the data more physiologically relevant, since resistance vessels are the main contributor to peripheral resistance, a key factor in blood pressure regulation. This may be especially important for ET1 because of its proven trophic and mitogenic effects via ET A receptors on SMCs in resistance arteries. 9 In vivo, SMCs of resistance arteries may have more exposure to endothelium-derived ET than SMCs of non-resistance arteries, since less connective tissue exists between the endothelium and the smooth muscle layers in resistance vessels. Lastly, the finding by Morris et al.
This editorial refers to 'Endothelin signalling in arterial smooth muscle is tightly regulated by G protein-coupled receptor kinase 2' by G.E. Morris et al., pp. 424-433, this issue.
At the heart of receptor-mediated signal transduction are two intertwined processes: translation of signals carried by stimulating agents to cells through intracellular messenger molecules and termination/ restriction of signalling by cells. The latter is a critical mechanism that protects cells from overreacting to an extended or appropriate stimulus and makes cells ready to react to forthcoming stimulation. G protein-coupled receptors (GPCRs) are a family of receptors composed of seven transmembrane domains that respond to various stimuli. GPCRs usually undergo rapid desensitization after activation, in which GPCR kinases (GRKs), a family consisting of seven members (GRK 1-7), play a critical role. 1 Endothelins (ETs) are a family of peptides comprising ET1, ET2, and ET3. 2 ETs exert their actions through two types of receptors, ET A and ET B , which belong to the GPCR family. 3 Activation of ET A receptors results in vasoconstriction through the generation of 1,4,5-inositol trisphosphate and diacylglycerol as intracellular messengers, which, in turn, trigger intracellular Ca 2þ release and protein kinase C activation.
Among the ET family members, ET1 is a potent vasoconstrictor that induces contraction at nanomolar concentrations in several vascular beds. 3 Significant desensitization of ET1-induced cellular response was soon reported after ET was discovered in 1988, 4 but the underlying mechanisms were not fully understood. Morris et al. 5 provide important, novel data regarding ET A receptor desensitization in vascular smooth muscle cells (SMCs) on several fronts. First, the study revealed a critical role of GRK2 in ET A receptor desensitization, with impressive evidence coming from multiple approaches, including 'real-time' confocal imaging, transfection with catalytically inactive GRK mutants and siRNA, and immunocytochemistry. The specificity of GRK2's involvement was confirmed because transfection with catalytically inactive mutants of several other isoforms (GRK3, GRK5, and GRK6) was not effective. Second, the data provide a better representation of in vivo ET receptor regulation when compared with data from non-SMC lines with recombinantly expressed ET receptors. This is because receptor types, quantity, and their micro-environment better represent the naturally expressed in vivo state in isolated native SMCs than in non-muscle cell lines.
Transfection often results in a supra-physiological level of expression of target genes, which may induce some artefacts such as increased formation of heterogeneous dimers between ET A and ET B receptors. suggesting that a broader spectrum of receptor interaction may exist in vivo. As rat mesenteric SMCs express ET A and ET B among many other receptors, native cells are certainly more suitable for receptor regulation studies than non-muscle cell lines. Third, the origin of the SMC makes the data more physiologically relevant, since resistance vessels are the main contributor to peripheral resistance, a key factor in blood pressure regulation. This may be especially important for ET1 because of its proven trophic and mitogenic effects via ET A receptors on SMCs in resistance arteries. 9 In vivo, SMCs of resistance arteries may have more exposure to endothelium-derived ET than SMCs of non-resistance arteries, since less connective tissue exists between the endothelium and the smooth muscle layers in resistance vessels. Lastly, the finding by Morris et al. 5 suggests that
GRKs might be a new target for therapeutic intervention, in addition to a currently available ET receptor antagonist (bosantan), as overexpression of GRK2 attenuated ET-induced SMC proliferation. ). The consequence of enhanced GRK2 on vessel tone will depend on which aspect prevails. Second, are ET B receptors desensitized in vascular smooth muscle and endothelial cells in a manner that is similar to the case with ET A receptors? The ET B receptor, also a member of the GPCR family, is present in SMCs (especially after organ culture),
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where it mediates contraction, and predominantly in endothelial cells, where it mediates endothelium-dependent vasodilation through NO and prostacyclin. 3 Whether ET A receptors were desensitized by GRK2 through phosphorylation-dependent or -independent mechanisms, 1 or both, remains to be determined, since ET receptor phosphorylation was not directly measured in this study. 5 Moreover, GRK2 may have a broader role than previously thought, since it also suppresses GPCR expression 15 or mediates cross-talk between two different categories of receptors. 12 Hence, further investigation is required to gain full understanding of GRK-mediated ET receptor desensitization in vascular tissues.
